Navigation Links
Kendle Delivers Record Net Service Revenues and New Business Authorizations for First Quarter 2008
Date:5/7/2008

serve related to potential collection issues with a specific customer, as well as higher than normal recruiting costs associated with the hiring of key executives and additional costs associated with building the company's infrastructure.

Net income was $5.6 million in first quarter 2008 compared to net income of $4.2 million for the same period of the prior year. Net service revenues by geographic region for the first quarter of 2008 were 46 percent in North America, 42 percent in Europe, 7 percent in Latin America and 5 percent in the Asia/Pacific region. Net service revenues by geographic region for the first quarter of 2007 were 50 percent in North America, 43 percent in Europe, 4 percent in Latin America and 3 percent in the Asia/Pacific region. The top five customers based on net service revenues accounted for 31 percent of net service revenues for first quarter 2008 compared to 26 percent of net service revenues for first quarter 2007. No single customer accounted for more than 10 percent of net service revenues in the three-month period ended March 31, 2008.

New business awards for first quarter 2008 were $180 million, which represents a 20 percent increase over the same quarter last year. Contract cancellations for the quarter were $25 million. Total business authorizations amounted to $917 million at March 31, 2008, up 6 percent from Dec. 31, 2007, and up 31 percent from March 31, 2007. The net book-to-bill ratio was 1.4 to 1 for both the three months ended March 31, 2008, and 2007.

"Kendle's results reflect strong and continued growth in net service revenues, new business awards and total business authorizations, all of which were record highs," said Candace Kendle, PharmD, Chairman and Chief Executive Officer. "During the quarter we saw a continued shift in our revenue distribution outside North America, marking the ongoing success of our globalization efforts and enhanced competitive position. We remain on target to meet the financi
'/>"/>

SOURCE Kendle International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Kendle Promotes Simon S. Higginbotham to President; Appoints Alan J. Boyce as Chief Marketing Officer
2. Kendle Delivers Strong Growth in Revenues, New Business Authorizations and Operating Margin for Full-Year 2007; Announces Guidance for 2008
3. Kendle Invites You to Attend Its Fourth Quarter and Year End 2007 Earnings Conference Call and Webcast
4. Kendle Appoints Industry Veteran to Lead Asia/Pacific Expansion
5. Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007
6. Kendle Appoints Ken Hintze, PhD, Vice President, Global Clinical Safety & Pharmacovigilance
7. Kendle Executive Dennis Hurley, DrSc to Present Keynote Address at DIA Latin American Congress 2007
8. Four Rivers Software Systems Delivers TMS WorkGroup 2008.3.3
9. New York Cigarette Tax Increase Delivers Victory for Kids and Taxpayers
10. FEW Announces Legislative Goals for Remainder of 110th Congress; Delivers Fact Sheets to Legislators
11. Ingenuity Systems Delivers Key Milestones in FDA Collaboration to Facilitate Genomic Data Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...LUMBIA, S.C., Nov. 21 U...ttee for Quality Assurance (NCQA) ranked BlueChoic... of America,s Best Health Plans(TM), published in ... , The respected annual ranking ranks the na..., member satisfaction and NCQA accreditation score...
(Date:11/21/2008)...periments in mice find running increases productio...21 (HealthDay News) -- In experiments in mice, exe...tion of brain stem cells usually seen with aging, ... restoration of the brain,s ability to stave off a...store a neurochemical that is essential for the pr...
(Date:11/21/2008)...RSAW, Ind., Nov. 21 Symm...ndent provider of products to the global orthopedi...nced today that Brian S. Moore, President and Chie... President and Chief Financial Officer, are schedu...alth Care Conference at The New York Palace Hotel ...
(Date:11/21/2008)...NNEAPOLIS, Nov. 21 Three Minnesota... prizes during a special on-ice presentation at,t...Energy Center. The winners,were participants in T...from,ClearWay Minnesota(SM) and QUITPLAN(R) Servi...$5,000 in cash, while two runners-up,will get $1,...
Breaking Medicine News(10 mins):Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:Exercise Keeps the Brain Young 2Health News:Lucky Quitters to Receive Big Money in Stop-Smoking Contest 2
... reported a study which states that fat men are ab.../This research was conducted by a team of research...this study, when obese men were hospitalized with ...ate better than thin men. This is said to be due t...
...al giant Novartis bagged the contract to make a ch...flu vaccines. The $54.8 million contract// was fin... than $300 million in federal contracts to fight a... in humans. Two other firms were also awarded con...
...searchers have developed a powerful method for cha...es called nucleosomes throughout the human genome/...clues for understanding and diagnosing cancer and ...may shed light on the role of nucleosomes in the p...
...y Commission said on Wednesday that about 375,000 ... Teether Beads are being recalled// because they p...at holds the teether beads in place can crack or b...e distributor, Kids II Inc. of Alpharetta, Ga., ha...
Other Medicine News:Health News:Scientists Map Key Landmarks in Human Genome 2Health News:Scientists Map Key Landmarks in Human Genome 3
(Date:11/20/2008)... PRELIMINARY TOP LINE RESULTS OF FIRST PHASE III ... FATIGUE, AND IMPROVEMENT IN DAILY FUNCTION, IN, ... , PALO ALTO, Calif., and BRUSSELS, Belgium, No...als, Inc. (Nasdaq: JAZZ ) and UCB (Euronext Brus...op-line results from the first of two,Phase III p...
(Date:11/20/2008)...VERSIDE, Calif., Nov. 20 Milk. It ...er than originally thought. After years of,resear...d peptides found in,cow,s milk that stimulate the... To view the Multimedia News Release, go to:, ht..., , While developing new cancer therapies, ...
(Date:11/20/2008)... JOLLA, Calif., Nov. 20 ...KA), announced today that it has submitted its,pi...eview under a Special,Protocol Assessment (SPA) p...n,(FDA). , Subject to securing an agreemen...e, prospective, double-blind, placebo-controlled a...
(Date:11/20/2008)...W YORK, Nov. 20 Clinical data from...e 35th Annual Veith Symposium shows DVT,treatment...om Bacchus,Vascular, Inc. (Santa Clara, CA) succe... in about 20 minutes. , This technique, cal...ores,blood flow more quickly and safely than curr...
Breaking Medicine Technology:Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 1Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 2Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 3Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 4Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 5Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 6Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 7Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 8Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 9Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 10Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 11Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 12Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 13Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 14Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 15Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 16Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 17Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 18Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 19Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 20Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 21Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 22Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 23Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 24Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics Inc s Drug Pipeline 6287 1Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics Inc s Drug Pipeline 6287 2Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics Inc s Drug Pipeline 6287 3Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics Inc s Drug Pipeline 6287 4Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics Inc s Drug Pipeline 6287 5Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics Inc s Drug Pipeline 6287 6Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics Inc s Drug Pipeline 6287 7Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics Inc s Drug Pipeline 6287 8Brokers Name Delta Dental the Best in Coverage Plan Design and Networks 6284 1Brokers Name Delta Dental the Best in Coverage Plan Design and Networks 6284 2New Global Health Video Footage Available Rights Free on GlobalHealthReporting org 6281 1New Global Health Video Footage Available Rights Free on GlobalHealthReporting org 6281 2New Global Health Video Footage Available Rights Free on GlobalHealthReporting org 6281 3
...USINESS WIRE)--Jun 7, 2007 - Clinical results from...the American,Headache Society (AHS) annual meeting...itonin gene-related peptide (CGRP),receptor antago...two hours after dosing compared to placebo, and th...as generally well tolerated in,the study. Response...
...hieves All Key Endpoints for Both Efficacy and Saf...irstCall/ --,Indevus Pharmaceuticals, Inc. today a...kinetic trial for NEBIDO (testosterone,undecanoate...under,development for the treatment of male hypogo...ing Pharma AG, Germany. The data,from the recently...
Other Medicine Technology:Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 2Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 3Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 4Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 5Indevus Reports Positive Data From Phase III NEBIDO Trial 2Indevus Reports Positive Data From Phase III NEBIDO Trial 3Indevus Reports Positive Data From Phase III NEBIDO Trial 4Indevus Reports Positive Data From Phase III NEBIDO Trial 5Indevus Reports Positive Data From Phase III NEBIDO Trial 6
Portable - Battery Powered (6 size AA required). Fast, Lightweight Strain Gage Mechanism. Unit conversion (g, ct, oz, ozt, GN, dwt, mom, dwt, tael), Specific Gravity calculation, Piece Counting and P
...speed, stability and durability. Back-lighted Disp...es, multiple units of measure, piece counting and .../ISO output including date and time data from buil...ights only (selectable range). Shimadzu WindowsDir...
...tal stability control, analog display modes, multi...easure functions, auto print, and GLP/GMP/ISO outp...k. Touch-key calibration with external weights (s...face, WindowsDirect Capable. 120/240V A/C adapter,...
The EK-H Series offer 10 selectable units of measure
Medicine Products: